Samaneh Zoghi

Samaneh Zoghi

Auto-generated profile, based on publicly available information

Samaneh Zoghi

Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2020 in Blood
Verified
Journal Article
Open access
PDF file
SGSujal Ghosh
Sujal Ghosh
SBSevgi Köstel Bal
Sevgi Köstel Bal
Edwards Emily S.J.Edwards Emily S.J.
Edwards Emily S.J.
BPBethany Pillay
Bethany Pillay
RHRaúl Jiménez Heredia
Raúl Jiménez Heredia
KBKaan Boztug
Kaan Boztug
Biallelic mutations in the genes encoding CD27 or its ligand CD70 underlie inborn errors of immunity (IEIs) characterized predominantly by Epstein-Barr virus (EBV)-associated immune dysregulation, such as chronic viremia, severe infectious mononucleosis, hemophagocytic lymphohistiocytosis (HLH), lymphoproliferation, and malignancy. A comprehensive understanding of the natural history, immune characteristics, and transplant outcomes has remained elusive. Here, in a multi-institutional global collaboration, we collected the clinical information of 49 patients from 29 families (CD27, n = 33; CD70, n = 16), including 24 previously unreported individuals and identified a total of 16 distinct mutations in CD27, and 8 in CD70, respectively. The majority of patients (90%) were EBV+ at diagnosis, but only ∼30% presented with infectious mononucleosis. Lymphoproliferation and lymphoma were the main clinical manifestations (70% and 43%, respectively), and 9 of the CD27-deficient patients developed HLH. Twenty-one patients (43%) developed autoinflammatory features including uveitis, arthritis, and periodic fever. Detailed immunological characterization revealed aberrant generation of memory B and T cells, including a paucity of EBV-specific T cells, and impaired effector function of CD8+ T cells, thereby providing mechanistic insight into cellular defects underpinning the clinical features of disrupted CD27/CD70 signaling. Nineteen patients underwent allogeneic hematopoietic stem cell transplantation (HSCT) prior to adulthood predominantly because of lymphoma, with 95% survival without disease recurrence. Our data highlight the marked predisposition to lymphoma of both CD27- and CD70-deficient patients. The excellent outcome after HSCT supports the timely implementation of this treatment modality particularly in patients presenting with malignant transformation to lymphoma.

11 April 2022 in Blood Advances
Verified
Journal Article
Open access
PDF file
TSTala Shahin
Tala Shahin
DMDaniel Mayr
Daniel Mayr
MSMohamed R. Shoeb
Mohamed R. Shoeb
HKHye Sun Kuehn
Hye Sun Kuehn
BHBirgit Hoeger
Birgit Hoeger
KBKaan Boztug
Kaan Boztug
Helios, encoded by IKZF2, is a member of the Ikaros family of transcription factors with pivotal roles in T-follicular helper, NK- and T-regulatory cell physiology. Somatic IKZF2 mutations are frequently found in lymphoid malignancies. Although germline mutations in IKZF1 and IKZF3 encoding Ikaros and Aiolos have recently been identified in patients with phenotypically similar immunodeficiency syndromes, the effect of germline mutations in IKZF2 on human hematopoiesis and immunity remains enigmatic. We identified germline IKZF2 mutations (one nonsense (p.R291X)- and 4 distinct missense variants) in six patients with systemic lupus erythematosus, immune thrombocytopenia or EBV-associated hemophagocytic lymphohistiocytosis. Patients exhibited hypogammaglobulinemia, decreased number of T-follicular helper and NK cells. Single-cell RNA sequencing of PBMCs from the patient carrying the R291X variant revealed upregulation of proinflammatory genes associated with T-cell receptor activation and T-cell exhaustion. Functional assays revealed the inability of HeliosR291X to homodimerize and bind target DNA as dimers. Moreover, proteomic analysis by proximity-dependent Biotin Identification revealed aberrant interaction of 3/5 Helios mutants with core components of the NuRD complex conveying HELIOS-mediated epigenetic and transcriptional dysregulation.

26 November 2021 in Science Immunology
Verified
Journal Article
Closed access
TSTala Shahin
Tala Shahin
HKHye Sun Kuehn
Hye Sun Kuehn
MSMohamed R. Shoeb
Mohamed R. Shoeb
LGLisa Gawriyski
Lisa Gawriyski
SGSarah Giuliani
Sarah Giuliani
KBKaan Boztug
Kaan Boztug
A homozygous mutation in IKZF2 disrupts the interactions of Helios with epigenetic remodelers, leading to impaired T cell activation.

3 July 2020 in Science Immunology
Verified
Journal Article
Closed access
ESElisabeth Salzer
Elisabeth Salzer
SZSamaneh Zoghi
Samaneh Zoghi
MKMáté G. Kiss
Máté G. Kiss
FKFrieda Kage
Frieda Kage
CRChristina Rashkova
Christina Rashkova
KBKaan Boztug
Kaan Boztug
HEM1 deficiency causes heritable autoimmunity and immunodeficiency.

31 August 2023 in Blood
Verified
Journal Article
Open access
SBSevgi Kostel Bal
Sevgi Kostel Bal
SGSarah Giuliani
Sarah Giuliani
JBJana Block
Jana Block
PRPeter Repiscak
Peter Repiscak
CHChristoph Hafemeister
Christoph Hafemeister
KBKaan Boztug
Kaan Boztug
The nuclear factor of activated T cells (NFAT) family of transcription factors plays central roles in adaptive immunity in murine models; however, their contribution to human immune homeostasis remains poorly defined. In a multigenerational pedigree, we identified 3 patients who carry germ line biallelic missense variants in NFATC1, presenting with recurrent infections, hypogammaglobulinemia, and decreased antibody responses. The compound heterozygous NFATC1 variants identified in these patients caused decreased stability and reduced the binding of DNA and interacting proteins. We observed defects in early activation and proliferation of T and B cells from these patients, amenable to rescue upon genetic reconstitution. Stimulation induced early T-cell activation and proliferation responses were delayed but not lost, reaching that of healthy controls at day 7, indicative of an adaptive capacity of the cells. Assessment of the metabolic capacity of patient T cells revealed that NFATc1 dysfunction rendered T cells unable to engage in glycolysis after stimulation, although oxidative metabolic processes were intact. We hypothesized that NFATc1-mutant T cells could compensate for the energy deficit due to defective glycolysis by using enhanced lipid metabolism as an adaptation, leading to a delayed, but not lost, activation responses. Indeed, we observed increased 13C-labeled palmitate incorporation into citrate, indicating higher fatty acid oxidation, and we demonstrated that metformin and rosiglitazone improved patient T-cell effector functions. Collectively, enabled by our molecular dissection of the consequences of loss-of-function NFATC1 mutations and extending the role of NFATc1 in human immunity beyond receptor signaling, we provide evidence of metabolic plasticity in the context of impaired glycolysis observed in patient T cells, alleviating delayed effector responses.

1 January 2021 in IDCases
Verified
Journal Article
Open access
NKNastaran Khalili
Nastaran Khalili
IMIraj Mohammadzadeh
Iraj Mohammadzadeh
NKNeda Khalili
Neda Khalili
RHRaúl Jimenez Heredia
Raúl Jimenez Heredia
SZSamaneh Zoghi
Samaneh Zoghi
NRNima Rezaei
Nima Rezaei
Patients with primary immunodeficiency disease (PID) are not only vulnerable to mycobacterial disease, but are also more likely to develop adverse events following BCG vaccination. These events can range from regional disease (BCGitis) to disseminated disease (BCGosis). Chronic granulomatous disease (CGD), which is characterized by impaired leukocyte phagocytic function, is one of the many inherited PIDs that increase the body’s susceptibility to recurrent bacterial and fungal infections. Here, we report a 6-year-old boy with no significant past medical history who presented with progressive lymphadenopathy six years after BCG vaccination. He was later diagnosed with CGD on further evaluation.